刑法中假药劣药二元分立之否定  

The Negation of Binary Separation between Fake Medicines and Medicines of Inferior Quality in Criminal Law

作　　者：桂亚胜[1] Gui Yasheng

机构地区：[1]上海对外经贸大学法学院

出　　处：《医学与法学》2018年第6期6-10,共5页Medicine and Jurisprudence

基　　金：国家社会科学基金项目"放弃治疗之法律规制研究"(项目编号:18BFX114)的阶段性成果

摘　　要：我国刑法中假药与劣药分立——并列规定了生产、销售假、劣药罪——源于《药品管理法》的规定,但该法的概念不能直接套用在刑法中;且假药与劣药的界限本身并不明确,在实务中难以区别。劣药的危害并不小于假药,二者在刑事责任上不应该有所不同,假药、劣药本质上都属于伪劣商品,可以统一在"伪劣药品"这单一概念之下,适用相同的犯罪构成和同一量刑幅度,故生产、销售假药罪和生产销售、劣药罪可以合并为一罪。In China,the separation of fake medicines and medicines of inferior quality in criminal law,in which the crime of producing or selling fake medicines and the crime of producing or selling medicines of inferior quality are both stipulated,comes from the provisions of Pharmaceutical Administration Law.But criminal law cannot use the concept of Pharmaceutical Administration Law directly.And the boundary between fake medicines and medicines of inferior quality is not clear and it is difficult to distinguish in practice.The harm of medicines of inferior quality is no less than that of fake medicines,so their criminal responsibility should not be different.In essence,fake medicines and inferior medicines belong to fake commodities,and they can be unified as an single concept that is fake or substandard medicines.Therefore,both of them can be applied to the same criminal constitution and the same sentence range,and the crime of producing or selling fake medicines and the crime of producing or selling medicines of inferior quality can merged into one crime.

关 键 词：假药 劣药 药品管理法 社会危害性 

分 类 号：D924.3[政治法律—刑法学]